[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 2014

Reperfusion of Large Ischemic Areas Associated With Central Retinal Vein Occlusion: A Potential Novel Treatment With Activated Protein C

Author Affiliations
  • 1Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan
JAMA Ophthalmol. 2014;132(3):361-362. doi:10.1001/jamaophthalmol.2013.6334

Central retinal vein occlusion (CRVO) severely threatens vision, especially in ischemic CRVO, for which no effective treatment has been established. Photocoagulation is the only treatment for retinal ischemia, which restores a balance between oxygen supply and demand by reducing the number of retinal cells. Considering its destructiveness, photocoagulation is not ideal. We report 2 cases with ischemic CRVO in which reperfusion of large ischemic areas occurred after novel treatment with an intraocular injection of activated protein C (APC).